The expression levels of NEAT1 were significantly higher in the PBMC of patients with RR‐MS compared to controls (p = 0.0002, FC = 1.78); the expression levels of KCNQ1OT1 were also significantly upregulated in RR‐MS patients (p < 0.0001, FC = 4.01). This evidence concerns the gene NEAT1 and myeloid sarcoma.